Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-088385
Filing Date
2021-07-01
Accepted
2021-07-01 18:35:25
Documents
1
Period of Report
2021-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121189-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121189-8_4seq1.xml 4 9585
  Complete submission text file 0001104659-21-088385.txt   10993
Mailing Address C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18 BOSTON MA 02116
Business Address
NIVEN RALPH (Reporting) CIK: 0001168060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 211067420

Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations